Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hMG + rFSH versus rFSH + rLH for ovarian stimulation in infertile women
IRCT2016092720351N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of human menopausal gonadotrophin, recombinant human follicle stimulating hormone and lutropin alfa in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Clinical pregnancy outcome. Started Oct 2014; status: completed.
02
Drugs
human menopausal gonadotrophinrecombinant human follicle stimulating hormonelutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT2016092720351N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016092720351N3.